Font Size: a A A

Clinical Analysis Of 20 Cases Of Pediatric Refractory Anemia With Excess Of Blasts

Posted on:2019-11-22Degree:MasterType:Thesis
Country:ChinaCandidate:N N DongFull Text:PDF
GTID:2394330545953855Subject:Pediatric Hematology and Tumor
Abstract/Summary:PDF Full Text Request
ObjectiveAnalyze the clinical data of the children with RAEB.MethodsTwenty pediatric RAEB were reclassified according to the criterion of 2015 edition the Chinese expert consensus for the diagnosis and treatment of childhood myelodysplastic syndrome.Twenty childhood diagnosed as RAEB in the department of Pediatric Hematology Oncology,the Fist Affiliated Hospital of Zhengzhou University between January 2010 and October 2017 were enrolled in the study.Clinical features,laboratory features,diagnosis,treatment,outcome dates and prognosis were retrospectively studied.Results13 males and 7 females were identified.Clinical symptoms were anemia(18cases,90%),fever(14cases,70%),hepatosplenomegaly(12 cases,60%),lymph node enlargement(5cases,25%),bleeding(6cases,30%),other symptoms(4cases,20%).Laboratory examinations : bone marrow proliferation was active(18cases,90%).Dysplasia was main features in bone marrow,two lineages and three lineages of hematopoietic dysplasia(17cases,85%).Abnormal chromosome were 3cases(15%).Treatment and outcomes:hematopoietic stem cell transplantation(HSCT)5 cases,chemotherapy 7cases,abandoned treatment 8 cases,converting into acute myeloid leukemia 6 cases(time range 1~26 months),died 12 cases(60%).Conclusion1.The male has higher incidence ratio during pediatric RAEB.2.The age can be a risk factor of scute onset for RAEB.3.Thrombocytopenia could be a risk factor of scute onset for pediatric RAEB,but the conclusion should be validated by more researches.4.The excess blasts could be a risk factor of scute onset for RAEB.5.FCM maybe an examination of abnormal blasts.6.Pediatric RAEB are characterized by a high death rate and a high rate of conversion to leukemia.Hematopeietic stem cell transplantation is the only treatment option with a realistic curative potential for pediatric RAEB.
Keywords/Search Tags:refractory anemia with excess of blasts, myelodysplastic syndromes, pediatric
PDF Full Text Request
Related items
Comparison Of The Efficacy And Safety Of Decitabine Alone Or Combined With Low-dose Chemotherapy In The Treatment Of Myelodysplastic Syndrome With Excess Blasts
A Comparative Study Of The Clinical And Biological Characteristics Of Myelodysplastic Syndromes With Excess Blasts-2 And Acute Myeloid Leukemia With Bone Marrow Blast Percentage Of 20-30%
Study Of The Efficacy Of Decitabine And Traditional Treatment On Myelodysplastic Syndrome With Excess Blasts(MDS-RAEB)
1.ASXL1 Down-regulation May Contribute To The Abnormal Migration Of SET2 And UKE1 Cells 2.Validation Of The WHO 2016 Proposals For Myelodysplastic Syndromes Patients With The Presence Of Ring Sideroblasts But Without Excess Blasts 3.Prognostic Evaluation
Mitophagy In Bone Marrow Nucleated Erythroid Cells Is Impaired And Related To Anemia In Patients With Myelodysplastic Syndromes
Clinical Outcome Of Treatment With A Combined Regimen Of Decitabine Followed By Low-dose Idarubicin And Cytarabine For Patients With High-risk Myelodysplastic Syndromes And AML Transformed From Myelodysplastic Syndromes(MDS/AML)
The Experimental And Clinical Research Of Iron Metabolism In Patients With Myelodysplastic Syndrome
Extensive Apoptosis And Ineffective Hematopoiesis In Megaloblastic Anemia And Myelodysplastic Syndromes
The Study On The Influence Of Busuishengxue Granule Combined With All-Trans Retinotic Acid To Bone Marrow C-met MRNA In Myelodyplastic Syndrome-Refractory Anemia
10 A Case Report:aplastic Anemia Transforms Into Myelodysplastic Syndrome And Then Develops Into Acute Myeloid Leukemia And Literature Review